Benefits Plans - Prescription Drug Plan: Drug Plan Updates and New Drug Releases - Drug Reviews

Page last updated: Wednesday, 26-May-2010 20:51:30 EDT

The following drug considerations were reviewed and determined for formulary inclusion and tier placement by the U-M Pharmaceutical Benefits Advisory Committee in July and August, 2004.

Drug Name Indication PDL Class
Yes/No
Action
Climara Pro Hormone Replacement Therapy Yes Tier 2
Avinza Pain Management Yes Tier 2
The following list of medications where moved to Tier 3
because of the availability of generic equivalents.
Darvocet N-100 & Darvocet N-50 Micro K 10meq   Rythmol
Dyazide 37.5/25 Pamelor   Soma
Glucotrol XL Permax   Soma Compound
Imuran Plaquenil   Tagamet
K-Dur Plexion   Tambocor
Klonopin Plexion SCT   Tylenol #3
Lorcet 10/650 Plexion TS   Vicodin ES
Maxzide& Maxzide-25 Purinethol    
Limitations
The University of Michigan in its sole discretion may modify, amend, or terminate the benefits provided with respect to any individual receiving benefits, including active employees, retirees, and their dependents. Although the university has elected to provide these benefits this year, no individual has a vested right to any of the benefits provided. Nothing in these materials gives any individual the right to continued benefits beyond the time the university modifies, amends, or terminates the benefit. Anyone seeking or accepting any of the benefits provided will be deemed to have accepted the terms of the benefits programs and the university's right to modify, amend or terminate them.